Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
12,615,886
-
Share change
-
+551,944
-
Total reported value
-
$66,609,144
-
Put/Call ratio
-
563%
-
Price per share
-
$5.28
-
Number of holders
-
61
-
Value change
-
+$2,514,033
-
Number of buys
-
36
-
Number of sells
-
18
Institutional Holders of MILLENDO THERAPEUTICS INC - COM (MLND) as of Q1 2020
As of 31 Mar 2020,
MILLENDO THERAPEUTICS INC - COM (MLND) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,615,886 shares.
The largest 10 holders included
NEA Management Company, LLC, GREAT POINT PARTNERS LLC, FRAZIER MANAGEMENT LLC, Bpifrance SA, BAKER BROS. ADVISORS LP, Samsara BioCapital, LLC, VANGUARD GROUP INC, BlackRock Inc., AWM Investment Company, Inc., and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
61
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.